Signify Premium Insight: FDA Approval for Samsung NeuroLogica as Interest in Photon Counting CT Grows
Published: March 31, 2022
Many leading medical imaging vendors have had photon-counting CT squarely in their sights for several years. While Siemens Healthineers, with its 2021 clearance, has made the most commercial headway on the systems so far, its competitors are not far behind, with Philips, GE, and Canon among those vendors working on their own systems. There is also good reason for this focus, with the new technology promising higher image quality, better signal to noise ratio, higher resolution and lower dose than current CT technologies. In particular, the technology will help radiologists more clearly distinguish between different tissue types and the composition of different tissues, bringing benefits to a whole raft of use cases, from oncology and stroke care, to cardiovascular and pulmonary care.